CAS 77378-06-4: 3′-Deoxy-N-(1-oxododecyl)adenosine

Applications A novel labelled N6-substituted Cordycepin derivative; an adenosine deaminase inhibitor. References Johns, D., et al.: Biochem. Pharmacol., 25, 1441 (1976), Muller, W., et al.: Cancer Res., 37, 3824 (1977), Sugar, A., et al.: Antimicrob. Agents Chemother., 42, 1424 (1998), Zhou, X., et al.: Eur. J. Pharmacol., 453, 309 (2002),

3'-Deoxy-N6-lauroyladenosine is a nucleoside analog that is used to treat cancer. It is a phosphoramidite compound and it has been shown to be highly active against cancer cells. 3'-Deoxy-N6-lauroyladenosine is an antiviral agent that inhibits viral DNA synthesis by competing with the natural substrate, deoxyribonucleosides, for incorporation into the growing DNA chain. It also prevents the replication of RNA viruses by inhibiting their transcription and translation processes. 3'-Deoxy-N6-lauroyladenosine also inhibits inflammation in the body and may act as a chemotherapeutic agent in other diseases such as diabetes, Alzheimer's disease, and Parkinson's disease.

Applications A novel N6-substituted Cordycepin derivative; an adenosine deaminase inhibitor. References Johns, D., et al.: Biochem. Pharmacol., 25, 1441 (1976), Muller, W., et al.: Cancer Res., 37, 3824 (1977), Sugar, A., et al.: Antimicrob. Agents Chemother., 42, 1424 (1998), Zhou, X., et al.: Eur. J. Pharmacol., 453, 309 (2002),